AstraZeneca's blood cancer drug meets main goal in late-stage trial
Posted by
www.biotecnika.org
The drug, Calquence, showed meaningful improvement in patients with
lymphocytic leukaemia when compared with a chemotherapy-based
treatment, the company said.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/astrazenecas-blood-cancer-drug-meets-main-goal-in-late-stage-trial/articleshow/69673241.cms
Subscribe to:
Post Comments (Atom)
Post a Comment